1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
Kouwenhoven, Mathilde C M
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. [electronic resource] - European journal of cancer (Oxford, England : 1990) Oct 2006 - 2499-503 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0959-8049
10.1016/j.ejca.2006.05.021 doi
Antineoplastic Agents, Alkylating--therapeutic use
Brain Neoplasms--drug therapy
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 19
Clinical Trials, Phase II as Topic
Dacarbazine--analogs & derivatives
Disease-Free Survival
Humans
In Situ Hybridization, Fluorescence
Multicenter Studies as Topic
Neoplasm Recurrence, Local--drug therapy
Oligodendroglioma--drug therapy
Prospective Studies
Salvage Therapy
Survival Analysis
Temozolomide
Treatment Outcome
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. [electronic resource] - European journal of cancer (Oxford, England : 1990) Oct 2006 - 2499-503 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0959-8049
10.1016/j.ejca.2006.05.021 doi
Antineoplastic Agents, Alkylating--therapeutic use
Brain Neoplasms--drug therapy
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 19
Clinical Trials, Phase II as Topic
Dacarbazine--analogs & derivatives
Disease-Free Survival
Humans
In Situ Hybridization, Fluorescence
Multicenter Studies as Topic
Neoplasm Recurrence, Local--drug therapy
Oligodendroglioma--drug therapy
Prospective Studies
Salvage Therapy
Survival Analysis
Temozolomide
Treatment Outcome